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To the Editor,
A 39-year-old female with acute myeloid leukemia was 
admitted to our transplantation clinic with face eruption 
without any pruritus. The eruption had occurred 28 days 
after she underwent an allogeneic hematopoietic stem cell 
transplantation (SCT). She was allografted with 6.12x106 non-
manipulated CD34+ cells from a fully matched sibling donor 
after a conditioning regimen including busulfan (12.8 mg/
m2), fludarabine (150 mg/m2), anti-thymocyte globulin (30 
mg/kg), and total body irradiation (400 Gy/day). Graft-versus-
host disease (GVHD) prophylaxis comprised methotrexate at 
12 mg/day for 3 days and cyclosporine A at 75 mg twice 
daily. No recent changes had been made to the medication. 
Neutrophil and thrombocyte engraftment both occurred on 
day 11. The toxicity related to the regimen was mild, being 
assigned the first grade for oral mucosa according to the 
Bearman scale [1]. The findings of the physical examination 
were patchy and confluent erythema of the face, suspicious 
for cutaneous acute GVHD. There were no other skin changes 
except that of the palms and soles. Neither intestinal nor 
hepatic acute GVHD occurred. Laboratory evaluation revealed 
a white blood cell count of 12,000/µL, a hemoglobin level of 
11.5 g/dL, a platelet count of 158,000/µL, and an absolute 
neutrophil count of 8400/µL. A 4-mm skin punch biopsy was 
performed [2]. There were lymphocytes and polymorphic 
neutrophils that attacked hair follicles and two Civatte 
bodies. Histochemically Demodex folliculorum was diagnosed 
with PAS staining within the hair follicles (Figures 1A and 
1B). Even with lymphocytes attacking hair follicles and 
Civatte bodies suggesting GVHD, Demodex folliculitis can 
mimic acute GVHD (Figures 1C and 1D). Demodicidosis was 
treated successfully with local 1% metronidazole and 5% 
permethrin. Methylprednisolone was also administered from 
the beginning of the symptoms and the dosing was reduced 
by 8 mg every week. The skin eruptions on the face and the 
neck resolved on day +52. 
Demodex folliculitis after allogeneic SCT is seen rarely and, as 
far as we know, our case is the sixth reported case [3,4,5,6]. 
The most important differential diagnosis of Demodex 
folliculitis within the first 100 days after allogeneic SCT is 
acute GVHD. The infestation by Demodex sp. can be associated 
with immune suppression. The differential diagnosis of facial 
erythema after bone marrow transplantation includes acute 
GVHD, drug eruptions, systemic lupus erythematosus, viral 
exanthema, toxic erythema of chemotherapy, drug-induced 
photosensitivity, and photodermatitis [3]. In our case there 
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were eruptions on the cheek, forehead, and jaw regions, 
which can be distinguished in both acute GVHD and Demodex 
folliculitis. However, the development of palmar erythema of 
the upper extremities is not a feature of demodicidosis. As 
confirmed by pathological examination, there were findings 
of both acute GVHD (presence of Civatte bodies, lymphocyte 
exocytosis, diffuse basal vacuolization in the epidermis) and 
demodicidosis (presence of Demodex folliculorum).
It should not be forgotten that GVHD may be associated with 
demodicidosis and Demodex infestation should be remembered 
in the differential diagnosis of eruptions in patients with 
hematological malignancies receiving chemotherapy and after 
SCT. For this reason, when the diagnosis of acute GVHD is 
ambiguous, an early skin biopsy has to be done after allogeneic 
SCT because early therapy for a possible Demodex infestation 
would prevent the progression of GVHD. 
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Figure 1. A) Demodex mite; B) Civatte body in the follicular 
epithelium containing Demodexand lymphocyte exocytosis; C) 
Civatte body in the epithelium far from the follicle; D) diffuse 
basal vacuolization in epidermis (periodic acid-schiff staining, 
magnification 40x) (159x119 mm; 72x72 DPI).
